NewsHour Weekend

  • La Lavra, Kiev, Russia
    April 27, 2014   BY Kristin Miller 

    NewsHour Weekend correspondent Megan Thompson talked with five experts on Russian and Ukrainian history and politics to dig a little deeper into what tensions underlie the current conflict. Below you’ll find additional writings from those experts, images from the Ukrainian past, and links to take your own exploration of over a thousand years of history deeper. Continue reading

  • Housing Development Credit: Michael Melford/Getty Images
    April 27, 2014  

    Recent reports suggest that the recovery in the nation’s housing market might be starting to slow down, with both existing and new home sales down in the last months. How will this affect the overall economic health in the country? Alison Stewart speaks with Michelle Conlin, a senior correspondent at Reuters, about trends in home sales during the last year. Continue reading

  • nationalpark
    April 27, 2014  

    It’s around this time every year that the Department of the Interior designates new national historic landmarks. There are roughly 2500 of them on the list: buildings, properties, even objects that represent important aspects of American history. This past week, four more were added to the list. Continue reading

  • Screen shot 2014-04-27 at 1.28.43 PM
    April 27, 2014  

    NewsHour Weekend explores the complicated histories of Russia and Ukraine. How are centuries-old tensions are playing out in today’s politics and rhetoric? Five scholars weigh in. Continue reading

  • Russian president Vladimir Putin has signed a law banning profanity in media and the arts .  Photo by Andrey Rudakov/Bloomberg
    April 26, 2014  

    Leaders from the Group of Seven have agreed to quickly impose more sanctions against Russia in response to the crisis in Ukraine. How will these measures affect Russia’s business partners in the West? Alison Stewart speaks with Stephen Szabo at the Transatlantic Academy about the significant economic ties between Europe and Russia. Continue reading

  • Photo by David Paul Morris/Getty Images
    April 26, 2014  

    Major tech companies including Apple, Adobe, Google and Intel have settled a huge class action lawsuit alleging they colluded not to go after each others’ employees, effectively holding down salaries. Alison Stewart talks with Arik Hessedahl of Re/code about the economic and social tensions troubling Silicon Valley. Continue reading

  • In October, a new rule goes into effect making it easier for people to safely dispose of unneeded prescription drugs throughout the year at participating retail pharmacies, hospitals, clinics, narcotic treatment programs and prescription drug manufacturers. Credit: Flickr user ep_jhu.
    April 20, 2014  

    A new study from Stanford University’s School of Medicine found that doctors who are allowed to hand out free samples of expensive drugs prescribe those drugs more often than doctors who don’t have access to free samples. Dr. Alfred Lane, senior author of the report, talks with Hari Sreenivasan about the implications of the findings. Continue reading

  • No_Comment_WEB2
    April 20, 2014  

    More and more websites are including online commenting as a feature for their visitors. But sometimes the comment boards become venues for rudeness and insults. These comments can influence how a reader perceives the story. Hari Sreenivasan speaks with web experts who help manage online communities and comments in different ways. Continue reading

  • Credit:  Franco Origlia/Getty Images
    April 20, 2014  

    Millions of Christians marked Easter Sunday in various forms with both Catholic and Orthodox celebrations landing on the same day. From the Vatican to Nigeria, Christians found ways to commemorate the end of the Holy Week, which celebrates the crucifixion and resurrection of Jesus. Continue reading

  • 20140419_KRIS
    April 19, 2014  

    There was word this week of what is being described as a pioneering clinical trial being done in the U.K. for patients with advanced lung cancer. What’s so novel about this development?Hari Sreenivasan spoke to Dr. Mark Kris, an oncologist at Memorial Sloan Kettering Cancer Center, about what makes this clinical trial so interesting. Continue reading